News

Found results: 3402

News

Rich people of St. Petersburg: Andrey Fomenko

Talking about his second brainchild, the Eternal Youth Foundation, Andrei Fomenko complains that his ideas for investing money in biotechnology, which would allow a person to live longer, have not yet found mass support among other oligarchs.

18.03.2009
News

Tasks of RUSNANO for the current year

One of the Corporation's priorities for 2009 is the formation of a pool of Russian and foreign investors interested in joining RUSNANO projects, as well as in acquiring a share of the Corporation after its exit from the project.

18.03.2009
News

Stem Cell Registry: St. Petersburg, 2012

By 2012, 10,000 stem cell samples should be harvested. Such a bank, according to doctors, will greatly simplify the treatment of hematological diseases – for example, leukemia.

17.03.2009
News

Biotechnology-2009

The Jubilee Fifth Moscow International Congress "Biotechnology: state and Prospects of Development" and the Seventh International Specialized Exhibition "World of Biotechnology 2009" began their work on March 16 this year.

17.03.2009
News

At what age does senile senility begin?

Respondents over the age of 27 showed a significant decrease in results in tests for logic, quick thinking and spatial imagination. Scientists have recorded memory deterioration in study participants over 37 years old; other intellectual functions begin to decline after 42 years.

17.03.2009
News

Do you want to live long? Don't slow down!

To the list of factors most associated with a person's longevity, another one was unexpectedly added, which was not particularly thought about before – the speed of a person's reaction to events happening around him.

16.03.2009
News

Google vs. Parkinsonism

Google creator Sergey Brin is personally interested in this: he inherited from his mother the G2019S mutation in the LRRK2 gene, which significantly increases the risk of developing Parkinson's disease.

13.03.2009
News

Anti-cancer genes in dendrimer packaging

Experiments on mice have shown that when such particles are introduced into the animal's body, they are captured exclusively by cancer cells, without causing any harm to healthy ones. After entering the cell, the genes "force" it to produce proteins that gradually kill tumor cells.

12.03.2009
News

How Stress Accelerates Aging

This discovery explains how stress reduces telomerase levels and thereby accelerates cell aging by increasing cortisol production.

11.03.2009
News

Bacteriophages will help antibiotics

The combination of antibiotics with therapy with bacteriophage viruses, which do not kill, but only weaken pathogenic bacteria, can significantly alleviate the fate of many patients in the future.

10.03.2009
News

The US President has allowed funding for stem cell research

While Barack Obama was signing the bill, representatives of a number of public and religious organizations gathered in front of the fence of the White House, which categorically do not accept experiments with human embryos.

10.03.2009
News

Bionic eyes: Second sight for the blind

There have already been 18 surgeries in the world to install the Argus II bionic eye, developed by the American company Second Sight for patients who have become blind as a result of retinal diseases.

05.03.2009
News

Sonodrugs: targeted drug delivery using microbubbles and ultrasound

The Sonodrugs project, designed for 4 years, combines several complex projects. This includes the main scientific developments concerning the development of a new type of particles of the required size, the required structure, the required physical behavior and biocompatibility, a set of works on laboratory tests of derived particles and a set of works on the evaluation of biological distribution in vivo and the effectiveness of drug delivery technology.

03.03.2009
News

Pharma 2020: another obstacle

The existing system of registration of medicines does not allow companies to quickly launch new generic and even more innovative products on the market.

03.03.2009
News

RUSNANO will help with the delivery of reagents

Russian manufacturers and scientists are placed in non-competitive conditions, when the delivery of reagents is carried out for 2 or more months at prices many times higher than the catalog. Solving this problem will reduce the risk of "brain drain" in the field of biotechnology, will facilitate the creation of innovative developments and reduce the production costs of companies working in the field of healthcare and biotechnology.

02.03.2009